Bernardo Cortese

May 21, 2024 | icrjournal.com | Roxana Mehran |Bernardo Cortese |Ling Tao |Ole De Backer

EuroPCR 24 - Dr Roxana Mehran (Mount Sinai Hospital, US) outlines the findings of the ABILITY Global Diabetes study onsite at EuroPCR 2024. The ABILITY study (NCT04236609) aimed to evaluate the efficacy and safety of the Abluminus DES+ Sirolimus Eluting Stent System (SES) as compared to the XIENCE Everolimus Eluting Coronary Stent System in diabetic patients eligible for percutaneous coronary intervention (PCI).

May 20, 2024 | icrjournal.com | Roxana Mehran |Bernardo Cortese |Joost Daemen

Video EuroPCR 2024: 4 Trials That Will Change My Practice with Dr Bernardo Cortese Published: 20 May 2024 Views: 143 Likes: 0 Average (ratings) No ratings EuroPCR 2024 - We are joined by Dr Bernardo Cortese (Ospedale Fate bene Fratelli, IT) for a concise and insightful summary of the late-breaking trials that are expected to have an impact on structural heart disease care.

Oct 3, 2023 | dialnet.unirioja.es | Bernardo Cortese

Alle frontiere dell’unione, tra cavalli di frisia e respingimenti a catena: Europa o …medusa? [1]Università di PadovaLocalización: Ordine Internazionale e Diritti Umani, ISSN-e 2284-3531, Nº. Extra 2, 2023 (Ejemplar dedicado a: Crisi Migratorie. Nuove sfide per i diritti umani), págs. 293-320Idioma: italianoTítulos paralelos: At the Borders of the Union, Amidst Chevaux de Frise and Chain-Pushbacks: Europa or Medusa?

Mar 17, 2023 | icrjournal.com | Bernardo Cortese |Joost Daemen

"- Welcome everybody, I am Bernardo Cortese, an interventional cardiologist from Milano for Fondazione Ricerca e Innovazione Cardiovascolare and DCB Academy and Cardio Parc, Lyon, France. What is the background of this trial? The background of study of EASTBOURNE dissection sub-study is very important from a technical point of view.